Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-26 @ 4:08 AM
Study NCT ID:
NCT00453427
Status:
COMPLETED
Last Update Posted:
2015-06-03
First Post:
2007-03-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas
Sponsor:
Ontario Clinical Oncology Group (OCOG)
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CTA-Control-103662
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None